Tenaya Therapeutics appoints new interim principal accounting officer
In a recent 8-K filing with the SEC, Tenaya Therapeutics, Inc. announced the appointment of Mr. Tomohiro Higa as the Interim Principal Accounting Officer (PAO), effective Thursday. Mr. Higa, who has ...
Spire Wealth Management Acquires New Position in Tenaya Therapeutics, Inc. (NASDAQ:TNYA)
Spire Wealth Management bought a new position in Tenaya Therapeutics, Inc. (NASDAQ:TNYA – Free Report) in the fourth quarter, ...
Tenaya Therapeutics’ (TNYA) “Buy” Rating Reiterated at HC Wainwright
HC Wainwright reissued their buy rating on shares of Tenaya Therapeutics (NASDAQ:TNYA – Free Report) in a research report ...
Business Insider1mon
Tenaya Therapeutics: Promising Pipeline and Upcoming Data Releases Support Buy Rating
Analyst Michael Ulz of Morgan Stanley maintained a Buy rating on Tenaya Therapeutics (TNYA – Research Report), retaining the price target of $15.00. Discover outperforming stocks and invest ...